Ready-to-ship engineered human and animal tissue products, for pharma research & testing to help global labs effectively insource their tissue engineering needs.
...driven by the desire to do good, help people and
improve the world
Retagen’s innovative solutions target challenges like disparate cell type approaches, suboptimal tissue health, efficient commercial scaling, humanized tissue development, and reduced adoption barriers. These efforts aim to revolutionise bioengineering, enhancing research impact and real-world applications through easy-to-adopt and shippable tissues.
Retagen’s goal is to simplify, generalise and humanise the way tissues are provided to labs. Streamlining production of tissues for different applications, bringing economies of scale, control and opportunity for further innovation.
Retagen’s unique strengths lie in its high throughput capabilities, tissue complexity, robustness, scalability, and flexible-cell use. It’s solutions offer application adaptability setting the stage for impactful and versatile advancements in bioengineering and research.
Retagen’s tissue engineering platform stands at the forefront of scientific innovation. Engineered to replicate the intricate structures and functionalities of human tissues, this advanced platform offers a transformative approach to research and medical applications.
Retagen’s tissue engineering platform stands at the forefront of scientific innovation. Engineered to replicate the intricate structures and functionalities of human tissues, this advanced platform offers a transformative approach to research and medical applications.
Retagen’s tissue engineering platform stands at the forefront of scientific innovation. Engineered to replicate the intricate structures and functionalities of human tissues, this advanced platform offers a transformative approach to research and medical applications.
Retagen leases its laboratory space to retain authority over its intellectual property, while also possessing ownership of its essential equipment.